Complications can include aortic dissection, joint dislocations, scoliosis, chronic pain, or early osteoarthritis.
The classification was last updated in 2017.
EDS is caused by mutations in one or more of 19 genes affecting collagen or tenascin.
Diagnosis is based on symptoms and genetic testing, although hypermobile EDS (hEDS) lacks a genetic marker.
Types of EDS
Hypermobile EDS (hEDS): Characterized by hypermobility of large and small joints, skin that is soft and velvety, and chronic pain.
Classical EDS: Features extremely elastic skin, joint hypermobility, molluscoid pseudotumors, and spheroids. Genetic variations in COL5A1, COL5A2, and COL1A1.
Vascular EDS: Skin is thin and translucent, fragile blood vessels. Characterized by thin skin and a high risk of arterial rupture. Genetic variations in COL3A1.
Brittle-Cornea Syndrome: Progressive thinning of the cornea, nearsightedness, hearing loss. Genetic variations in ZNF469 and PRDM5.
Arthrochalasia EDS: Severe joint hypermobility, congenital hip dislocation. Genetic variations in COL1A1 and COL1A2.
Kyphoscoliosis EDS: Severe hypotonia, progressive scoliosis, and osteopenia. Genetic variations in PLOD1 or FKBP14.
Diagnosis and Treatment
Diagnosis often involves genetic testing and physical examination.
Beighton criteria are used to assess joint hypermobility.
Treatment is supportive, including physical therapy, bracing, and pain management.
No known cure; management focuses on alleviating symptoms.